ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

9,185Medicare Part D Prescriptions Filled, Including Refills

Rank: 234 out of 2094

$586K Total Retail Price of All Prescriptions

Rank: 365 out of 2094

350 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
78% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New Jersey
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 350 patients filled at least one prescription for a schedule two drug, compared to an average of 6%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 6,693 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

32% of this provider’s prescriptions were for brand-name drugs, compared to an average of 32%.

Prescription Price

$64 was the average price of a prescription from this provider, compared to $78 among peers.

Prescriptions per Patient

26 is the average number of prescriptions (including refills) per patient, compared to an average of 17.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New Jersey
SIMVASTATIN 462 344 1 1
AMLODIPINE BESYLATE 331 273 2 2
LISINOPRIL-HYDROCHLOROTHIAZIDE 330 259 3 55
METFORMIN HCL 257 170 4 8
PRAVASTATIN SODIUM 253 139 5 18
METOPROLOL SUCCINATE 252 186 6 9
OMEPRAZOLE 250 166 7 4
ATORVASTATIN CALCIUM 232 195 8 5
MELOXICAM 231 199 9 49
LEVOTHYROXINE SODIUM 225 202 10 3
JANUVIA 210 146 11 35
ENALAPRIL MALEATE 205 140 12 25
CRESTOR 202 171 13 15
CLOPIDOGREL 138 120 14 22
LISINOPRIL 118 78 15 7
FUROSEMIDE 112 90 16 6
IBUPROFEN 111 58 17 73
ALENDRONATE SODIUM 106 85 18 30
JANUMET 103 67 19 86
CARVEDILOL 103 88 19 19
ATENOLOL 97 81 21 21
HYDROCHLOROTHIAZIDE 95 75 22 12
EVISTA 92 69 23 131
RAMIPRIL 91 89 24 48
PLAVIX 91 84 24 38
GLIMEPIRIDE 86 67 26 31
ZOLPIDEM TARTRATE 84 65 27 14
AMITRIPTYLINE HCL 82 52 R 28 178
NEXIUM 78 61 29 16
LOSARTAN POTASSIUM 75 50 30 17
METOPROLOL TARTRATE 75 47 30 10
TAMSULOSIN HCL 74 69 32 29
LOSARTAN-HYDROCHLOROTHIAZIDE 74 55 32 52
CELEBREX 73 36 34 74
DIOVAN HCT 71 60 35 28
AZITHROMYCIN 65 47 36 27
SERTRALINE HCL 65 49 36 26
PROAIR HFA 64 28 38 45
ADVAIR DISKUS 60 52 39 36
POTASSIUM CHLORIDE 58 32 40 24
LIPITOR 57 53 41 39
SPIRIVA 55 55 42 60
CIPROFLOXACIN HCL 54 44 43 81
TRAMADOL HCL 52 12 44 33
ISOSORBIDE MONONITRATE ER 51 42 45 57
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Dec. 6, 2010.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.